Document is current
Any future updates will be listed below
-
Authors
Heath, Elisabeth I. https://orcid.org/0000-0003-1381-2713
Chen, Wei
Choi, Jae E.
Dobson, Kimberlee
Smith, Melanie
Maj, Tomasz
Kryczek, Ilona
Zou, Weiping
Chinnaiyan, Arul M.
Qiao, Yuanyuan
-
Funding
Funding for this research was provided by:
National Cancer Institute, United States (P30CA022453-3)
National Cancer Institute, United States (5P50CA186786-10)
Esanik Therapeutics
U.S. Department of Defense (HT9425-23-1-0084)
- License Information
-
More Information
Article History
Received: 29 September 2024
Accepted: 23 October 2024
First Online: 6 November 2024
Declarations
:
: The study was approved by the Wayne State University Institutional Review Board. All patients signed an Informed Consent form prior to participating in the study.
: Arul M. Chinnaiyan serves on the Scientific Advisory Board and is a co-founder of Esanik Therapeutics. Esanik partially funded this clinical study but was not involved in study design or conduct.
